Kingsley began investing in the emerging legalised cannabis market in 2015, and is the only investment firm outside of the US to do so on a formal basis
Kingsley is the only firm to take a global approach to the legalised cannabis market and has foundcreated two operating companies in the sector: Oxford Cannabinoid Technologies and Equinox International.
Should you be interested in investing in this high-growth sector, please contact firstname.lastname@example.org for more information.
Oxford Cannabinoid Technologies
About: OCT was founded in 2017 with its lead research partner, Oxford University, OCT is studying the molecular properties of cannabinoids and is developing cannabinoid-derived medication across cancer, pain, immunology and neurological conditions.
About: Equinox is an international cultivation and retail business focused on the UK and non-US markets.